No better than LMWH in preventing pulmonary embolism

Prescrire International

Volumn 12, Issue 63, 2003, Pages 3-5

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; FONDAPARINUX; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; BLEEDING; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELDERLY CARE; FRACTURE TREATMENT; HIP FRACTURE; HUMAN; KIDNEY FAILURE; KNEE ARTHROPLASTY; LICENCE; LUNG EMBOLISM; MORTALITY; NONHUMAN; ORTHOPEDIC SURGERY; PATIENT MONITORING; PHLEBOGRAPHY; PROPHYLAXIS; RABBIT; RAT; RISK ASSESSMENT; SYMPTOM; TERATOGENICITY; THROMBOCYTOPENIA; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0037939992     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prescrire Rédaction "Prévention primaire des embolies pulmonaires" Rev Prescr 2002; 22 (230): 526.
2. Prescrire Rédaction "Prévention primaire des embolies pulmonaires: choisir selon la situation" Rev Prescr 2002; 22 (230): 516-529.
3. Food and Drug Administration - Center for drug evaluation and research "Application number 21-345 - fondaparinux - Medical Officer's review" 13 July 2001: 212 pages.
4. Eriksson BI et al. "Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery" N Engl J Med 2001; 345 (18): 1298-1304.
5. Bauer KA et al. "Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery" N Engl J Med 2001; 345 (18): 1305-1310.
6. Turpie AGG et al. "A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement" N Engl J Med 2001; 344 (9): 619-625.
7. Lassen MR et al. "Postoperative fondaparinux versus preoperative enoxaparine for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison" Lancet 2002; 359 (9319): 1715-1720.
8. Turpie AGG et al. "Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial" Lancet 2002; 359 (9319): 1721-1726.
9. Prescrire Rédaction "De la thrombose veineuse à l'embolie pulmonaire" Rev Prescr 2002; 22 (229): 442.
10. Food and Drug Administration - Center for drug evaluation and research "Application number 21-345 - fondaparinux - Memorandum" 19 July 2001: 23 pages.
11. Food and Drug Administration - Center for drug evaluation and research "Application number 21-345 - fondaparinux - Final printed labeling" 7 December 2001: 22 pages.
12. EU Commission "Summary of product characteristics - Arixtra" 21 March 2002; 9 pages
13. Sanofi-Synthelabo "Arixtra" brochure promotionnelle (undated): 84-85.
14. Majerus PW and Tollefsen DM "Anticoagulant, thrombolytic and antiplatelet drugs". In: Hardman JG et al. "Goodman and Gilman's The pharmacological basis of therapeutics" 10th ed, Mc Graw-Hill New York 2001: 1519-1538.
15. Hirsh J and Levine MN "Low molecular weight heparin" Blood 1992; 79: 1-17.